Intravitreal triamcinolone acetonide for macular edema associated with diabetic retinopathy and venous occlusive disease: it's time for clinical trials

Arch Ophthalmol. 2005 Feb;123(2):258-9. doi: 10.1001/archopht.123.2.258.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Trials as Topic*
  • Diabetic Retinopathy / complications
  • Diabetic Retinopathy / drug therapy*
  • Glucocorticoids / therapeutic use*
  • Humans
  • Macular Edema / drug therapy*
  • Macular Edema / etiology
  • Retinal Vein Occlusion / complications
  • Retinal Vein Occlusion / drug therapy*
  • Triamcinolone Acetonide / therapeutic use*
  • Vitreous Body

Substances

  • Glucocorticoids
  • Triamcinolone Acetonide